A detailed history of Ballentine Partners, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 11,596 shares of MCK stock, worth $5.63 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
11,596
Previous 11,261 2.97%
Holding current value
$5.63 Million
Previous $6.05 Million 12.03%
% of portfolio
0.13%
Previous 0.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$518.81 - $607.81 $173,801 - $203,616
335 Added 2.97%
11,596 $6.77 Million
Q1 2024

Apr 11, 2024

BUY
$473.42 - $539.26 $324,766 - $369,932
686 Added 6.49%
11,261 $6.05 Million
Q4 2023

Jan 23, 2024

SELL
$437.42 - $470.64 $199,026 - $214,141
-455 Reduced 4.13%
10,575 $4.9 Million
Q3 2023

Oct 19, 2023

SELL
$402.4 - $446.42 $457,931 - $508,025
-1,138 Reduced 9.35%
11,030 $4.8 Million
Q2 2023

Jul 26, 2023

SELL
$354.01 - $427.31 $106,557 - $128,620
-301 Reduced 2.41%
12,168 $5.2 Million
Q1 2023

Apr 27, 2023

BUY
$335.35 - $386.06 $387,664 - $446,285
1,156 Added 10.22%
12,469 $4.44 Million
Q4 2022

Jan 27, 2023

BUY
$346.68 - $397.58 $534,233 - $612,670
1,541 Added 15.77%
11,313 $0
Q3 2022

Oct 26, 2022

BUY
$321.25 - $373.84 $90,271 - $105,049
281 Added 2.96%
9,772 $3.32 Million
Q2 2022

Aug 09, 2022

SELL
$300.57 - $336.42 $395,249 - $442,392
-1,315 Reduced 12.17%
9,491 $3.1 Million
Q1 2022

May 05, 2022

BUY
$244.61 - $310.48 $9,539 - $12,108
39 Added 0.36%
10,806 $3.31 Million
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $9,315 - $11,698
47 Added 0.44%
10,767 $2.68 Million
Q3 2021

Oct 27, 2021

BUY
$188.42 - $208.66 $1,695 - $1,877
9 Added 0.08%
10,720 $2.14 Million
Q2 2021

Aug 12, 2021

BUY
$184.89 - $202.68 $112,413 - $123,229
608 Added 6.02%
10,711 $2.05 Million
Q1 2021

May 11, 2021

SELL
$169.52 - $196.53 $34,751 - $40,288
-205 Reduced 1.99%
10,103 $1.97 Million
Q4 2020

Jan 25, 2021

SELL
$143.79 - $183.66 $70,313 - $89,809
-489 Reduced 4.53%
10,308 $1.79 Million
Q3 2020

Oct 22, 2020

BUY
$140.89 - $159.9 $27,896 - $31,660
198 Added 1.87%
10,797 $1.61 Million
Q2 2020

Jul 31, 2020

SELL
$125.49 - $164.68 $312,721 - $410,382
-2,492 Reduced 19.04%
10,599 $1.63 Million
Q1 2020

Apr 23, 2020

BUY
$115.75 - $170.96 $810 - $1,196
7 Added 0.05%
13,091 $1.77 Million
Q4 2019

Jan 22, 2020

BUY
$130.23 - $153.27 $26,045 - $30,654
200 Added 1.55%
13,084 $1.81 Million
Q3 2019

Oct 21, 2019

SELL
$134.24 - $148.53 $21,075 - $23,319
-157 Reduced 1.2%
12,884 $1.76 Million
Q2 2019

Jul 25, 2019

BUY
$112.47 - $134.93 $1.14 Million - $1.36 Million
10,103 Added 343.87%
13,041 $1.75 Million
Q1 2019

May 09, 2019

BUY
$111.86 - $136.3 $4,809 - $5,860
43 Added 1.49%
2,938 $344,000
Q4 2018

Feb 04, 2019

BUY
$108.23 - $136.84 $20,455 - $25,862
189 Added 6.98%
2,895 $320,000
Q3 2018

Oct 30, 2018

SELL
$123.14 - $138.52 $18,594 - $20,916
-151 Reduced 5.29%
2,706 $359,000
Q2 2018

Jul 19, 2018

BUY
$133.4 - $158.13 $381,123 - $451,777
2,857 New
2,857 $381,000
Q1 2018

Apr 26, 2018

SELL
$138.75 - $176.72 $188,283 - $239,809
-1,357 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$135.02 - $162.6 $3,510 - $4,227
26 Added 1.95%
1,357 $212,000
Q3 2017

Nov 06, 2017

BUY
$146.0 - $161.87 $194,326 - $215,448
1,331
1,331 $204,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $69.8B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.